COVID-19 Antibody Testing Among Get Well Loop Participants
- Funded by University of Minnesota
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$0Funder
University of MinnesotaPrincipal Investigator
MD. Pita AdamResearch Location
United States of AmericaLead Research Institution
Medical School, University of MinnesotaResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Led by Pita Adam, MD, MSPH, vice chair for clinical affairs, Department of Family Medicine and Community Health, this study builds upon current research that is utilizing the electronic health record Epic and GWL database to prospectively monitor presumptive COVID-19 patients and compare outcomes between GWL patients and those who did not enroll. "By conducting post-illness antibody testing with the GWL sample, we can clearly define the subgroup who had COVID-19 and better define the symptom complex and natural course of COVID-19 as well as explore risk factors for severe outcomes," said Adam.